Skip to main content
Not Found
On Demand

New Era of Anti-Obesity Medications

Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
State Associations:
OPSC - California
Faculty:
Michelle Look, MD, MD
Duration:
1 Hour 03 Minutes
Expiration:
Never Expires.
View Demo  Add to Cart »

Description

** Please note this program was featured in OPSC's 35th Annual Fall Conference, CME by the Bay 2024, held in Monterey, California. If you attended this event in person or purchased the digital edition, you will not qualify for CME credits by participating in the program. ** 

Embark on a transformative journey into the New Era of Anti-obesity Medications with this presentation. Uncover cutting-edge pharmaceutical advancements of current AOM/s as well as those in development that are reshaping the landscape of weight management. Understand why long-term treatment of the chronic disease of obesity with lifestyle interventions and medication makes sense and its impact on other chronic diseases.
 
This session challenges previous treatment paradigms, offering primary care providers a comprehensive understanding of the evolving treatment of obesity. After decades of limited options, we've entered a new era in which we have anti-obesity medications that produce 15-20% or more weight reduction and are improving health in ways that we've never seen before.
 
Learning Objectives:
  • Recognize and prioritize obesity as a chronic, progressive relapsing disease that requires a comprehensive, long-term treatment approach.
  • Identify the goals of obesity treatment using pharmacotherapy.
  • Implement an evidence-based, stepwise, comprehensive treatment plan that includes pharmacotherapy.
  • Discuss how pharmacotherapeutic approaches can both enhance initial weight reduction and improve weight maintenance.

Disclosures: Boehringer Ingelheim: consultant, advisory board; Eli Lilly: Speaker, consultant, advisory board

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the AOA to provide osteopathic continuing medical education for physicians. 

Grievance Policy: Osteopathic Physicians and Surgeons of California (OPSC) strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at (916) 822-5246 or by email at opsc@opsc.org. 

Handouts

New Era of Anti-Obesity Medications (4.3 MB) 58 Pages Available after Purchase

Faculty

Michelle Look, MD, MD Related Seminars and Products

Dr. Michelle Look joined San Diego Sports Medicine & Family Health Center (SDSM) in 2001 after completing its Primary Care Sports Medicine fellowship program and a Family Practice residency at Sharp Healthcare in San Diego. She graduated from Jefferson Medical College and is board certified in family medicine and obesity medicine, with added qualifications in sports medicine. Dr. Look serves on the Board of Directors for the American Heart Association San Diego Chapter and was the National Medical Director for the Susan G. Komen for the Cure Breast Cancer 3-Day Walk for several years. She was a team physician for the United States 2008 Summer Olympics in Beijing, China, and 2010 Winter Olympics in Vancouver, Canada.

Reviews

Back to Top